Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

首次发布于 2020 年 6 月 26 日

Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

计划入组 49 人 · 首次发布于 2013 年 7 月 10 日

Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study

计划入组 307 人 · 首次发布于 2021 年 11 月 11 日

KBI-436

GPR119 agonists (Japan Tobacco)

Encochleated amphotericin B (Matinas BioPharma)

KBI Biopharma, Inc.

United States

PFIZER JAPAN INC.

Japan

ALCON JAPAN LTD.

Japan

Japan Signals Strategic Shift Toward Open Innovation and Cross-Border Biotech Collaboration at BIO Asia–Taiwan 2026

KBI Biopharma Partners with Infinimmune to Advance Human-First Antibody Manufacturing for Atopic Dermatitis

Novotech Strengthens Presence in Japan with Opening of Tokyo Office